My newest HIV animation, this one is on PrEP (and we voyage inside MY BODY). Please leave us a like and/or comment and/or subscribe to the channel!
In this episode, Doc Griggs and I are joined by Milan Nicole Sherry, a trans rights activist and educator. Together, the group journeys inside of Dr. Dery’s body to explain the science of HIV and PrEP (pre-exposure prophylaxis).
To examine the association between Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) use and the development of glaucoma in individuals with type 2 diabetes.
Audio Interview from the New England Journal of Medicine — Injured, Not Sidelined — NOS Episode 2.10
ype 1 or type 2 diabetes mellitus with painful distal symmetric sensorimotor neuropathy of >6 months’ duration and neuropathic pain were enrolled and randomized 1:1…
Alicia Morgans interviews Neeraj Agarwal about the CONTACT-02 trial, a phase III study that explores the combination of cabozantinib and atezolizumab in patients with metastatic…
This JAMA Patient Page describes hepatitis D infection and its risk factors, outcomes of acute and chronic infection, diagnosis, treatment, and prevention.
This case series examines the improvement in port-wine birthmark clearance from before to after once-weekly pulsed dye laser therapy in patients younger than 6 months.
This case series examines the improvement in port-wine birthmark clearance from before to after once-weekly pulsed dye laser therapy in patients younger than 6 months.
This cluster randomized clinical trial examines the effectiveness of an electronic health record–based population health management intervention vs usual care for reducing chronic kidney disease…
This JAMA Patient Page describes hepatitis D infection and its risk factors, outcomes of acute and chronic infection, diagnosis, treatment, and prevention.
